SCHEMBL4530549

SCHEMBL4530549

COc1ccc(Cn2cnc3c(NCCc4cc5cccc(Cl)c5c(CCN5CCOCC5)n4)ncnc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.41
KDM4E B2RXH2 4/20 0.41
RAB9A P51151 2/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2D6 P10635 2/20 0.41
USP2 O75604 2/20 0.41
CLK4 Q9HAZ1 1/20 0.41
PDE10A Q9Y233 1/20 0.41
KMT2A Q03164 5/20 0.40
MEN1 O00255 4/20 0.40
HTT P42858 3/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 4/20 0.40
NPC1 O15118 1/20 0.40
TP53 P04637 3/20 0.40
LMNA P02545 2/20 0.40
ALOX15 P16050 1/20 0.40
HIF1A Q16665 1/20 0.40
HPGD P15428 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4539397 0.94 PDE10A (0.41) ALDH1A1KDM4ERAB9ACYP1A2CYP3A4
SCHEMBL3703540 0.86 PDE10A (0.40) ALDH1A1KDM4ERAB9APDE10AKMT2A
SCHEMBL3703537 0.86 PDE10A (0.40) ALDH1A1KDM4ERAB9APDE10AKMT2A
SCHEMBL4542862 0.84 HTT (0.45) HTTTP53LMNAHPGDHDAC1
SCHEMBL4534986 0.81 HDAC1 (0.44) KDM4EKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4539184 0.81 HDAC1 (0.43) KDM4EKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4539338 0.81 CTSL (0.47) HTTTP53LMNAHPGDHDAC1
SCHEMBL4530998 0.81 HDAC1 (0.47) KDM4EKMT2AMEN1HTTSMN1; SMN2
SCHEMBL4540473 0.80 HDAC1 (0.37) HTTTP53LMNAHPGDHDAC1
SCHEMBL4564684 0.80 HDAC1 (0.42) KMT2AMEN1HTTTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2637669-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF Infinity Pharmaceuticals, Inc. (US) 2013-09-18 EP disclosed
WO-2012064973-A2 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2012-05-18 WO disclosed